Literature DB >> 12200200

Diabetic neuropathies in brain are induced by deficiency of BDNF.

A Nitta1, R Murai, N Suzuki, H Ito, H Nomoto, G Katoh, Y Furukawa, S Furukawa.   

Abstract

Diabetes is known to be one of the risk factors for dementia; however, neuropathic changes in the brain of patients with the disease have not been completely revealed. So in the present study, we investigated the brain function of rats with diabetes induced by streptozotocin (STZ), one of the most commonly used animal models for diabetes. In the diabetic rats, immediately working memory performance was impaired in the Y-maze task and neuronal cytoskeleton proteins such as calbindin, synaptophysin, and syntaxin were reduced. Furthermore, morphological observation by Golgi staining showed a decrease in the number of basal dendrites and abnormality of spine structure. Next, we measured the content of brain-derived neurotrophic factor (BDNF) in the diabetic brain, because BDNF is one of the essential proteins for the maintenance of neuronal functions including synapse function and neuronal transmissions. In the diabetic brains, both protein and mRNA levels of BDNF were severely reduced. These results suggest that, in diabetes, synapse dysfunction is, at least in part, caused by a failure of BDNF synthesis in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200200     DOI: 10.1016/s0892-0362(02)00220-9

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  41 in total

1.  Depressive phenotypes evoked by experimental diabetes are reversed by insulin.

Authors:  Nancy Ho; Darrick T Balu; Monica R F Hilario; Julie A Blendy; Irwin Lucki
Journal:  Physiol Behav       Date:  2011-09-10

Review 2.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

3.  Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment.

Authors:  Flavia E Saravia; Juan Beauquis; Yanina Revsin; Francoise Homo-Delarche; E Ronald de Kloet; Alejandro F De Nicola
Journal:  Cell Mol Neurobiol       Date:  2006-06-29       Impact factor: 5.046

4.  Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats.

Authors:  Mohammad S Ola; Abdulaziz M Aleisa; Salim S Al-Rejaie; Hatem M Abuohashish; Mihir Y Parmar; Abdullah S Alhomida; Mohammed M Ahmed
Journal:  Neurol Sci       Date:  2014-01-11       Impact factor: 3.307

5.  Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms.

Authors:  Javad Fahanik-Babaei; Tourandokht Baluchnejadmojarad; Farnaz Nikbakht; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2018-11-12       Impact factor: 3.584

Review 6.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

7.  Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice.

Authors:  Juan Beauquis; Paulina Roig; Alejandro F De Nicola; Flavia Saravia
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

8.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

9.  Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.

Authors:  Lascelles E Lyn-Cook; Margot Lawton; Ming Tong; Elizabeth Silbermann; Lisa Longato; Ping Jiao; Princess Mark; Jack R Wands; Haiyan Xu; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.

Authors:  Suzanne M de la Monte; Ming Tong; Margot Lawton; Lisa Longato
Journal:  Mol Neurodegener       Date:  2009-12-24       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.